Dr. Edlind is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3322 N Broad St
Philadelphia, PA 19140Phone+1 215-707-1800Fax+1 215-707-3644
Education & Training
Perelman School of Medicine at the University of PennsylvaniaClass of 2017
University of Pennsylvania Health SystemResidency, Internal Medicine
Certifications & Licensure
PA State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 192 citationsPI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistanceMerritt Edlind, Andrew C. Hsieh
Asian Journal of Andrology. 2014-05-01 - 979 citationsThe translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C. Hsieh, Yi Liu, Merritt Edlind, Nicholas T. Ingolia, Matthew R. Janes
Nature. 2012-05-03 - 34 citationsCell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitorsAndrew C. Hsieh, Hao G. Nguyen, Lexiaochuan Wen, Merritt Edlind, Peter R. Carroll
Science Signaling. 2015-11-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
